These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of Gastroparesis. Hasler WL; Lee AA; Moshiree B; Surjanhata BC; Rao S; Parkman HP; Nguyen LA; Sarosiek I; Wo JM; Schulman MI; McCallum RW; Kuo B Clin Gastroenterol Hepatol; 2024 Apr; 22(4):867-877.e12. PubMed ID: 37913936 [TBL] [Abstract][Full Text] [Related]
43. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Anaparthy R; Pehlivanov N; Grady J; Yimei H; Pasricha PJ Dig Dis Sci; 2009 May; 54(5):1003-10. PubMed ID: 19277867 [TBL] [Abstract][Full Text] [Related]
44. Gastroparesis Updates on Pathogenesis and Management. Liu N; Abell T Gut Liver; 2017 Sep; 11(5):579-589. PubMed ID: 28535580 [TBL] [Abstract][Full Text] [Related]
45. Gastric Electrical Stimulation Is an Effective Treatment Modality for Refractory Gastroparesis in a Postsurgical Patient with Pancreatic Cancer. Doshi S; Patel A; Stocker A; Scoggins C; Agrawal L; Abell T Case Rep Gastroenterol; 2019; 13(3):430-437. PubMed ID: 31762731 [TBL] [Abstract][Full Text] [Related]
46. Safety and Feasibility of Per-Oral Pyloromyotomy as Augmentative Therapy after Prior Gastric Electrical Stimulation for Gastroparesis. Strong AT; Rodriguez J; Kroh M; Ponsky J; Cline M; El-Hayek K J Am Coll Surg; 2019 Dec; 229(6):589-595. PubMed ID: 31610231 [TBL] [Abstract][Full Text] [Related]
47. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis. Revicki DA; Lavoie S; Speck RM; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP J Patient Rep Outcomes; 2018 Dec; 2(1):61. PubMed ID: 30547386 [TBL] [Abstract][Full Text] [Related]
48. Does etiology of gastroparesis determine clinical outcomes in gastric electrical stimulation treatment of gastroparesis? Kim D; Gedney R; Allen S; Zlomke H; Winter E; Craver J; Pinnola AD; Lancaster W; Adams D Surg Endosc; 2021 Aug; 35(8):4550-4554. PubMed ID: 32909214 [TBL] [Abstract][Full Text] [Related]
49. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Pasricha PJ; Colvin R; Yates K; Hasler WL; Abell TL; Unalp-Arida A; Nguyen L; Farrugia G; Koch KL; Parkman HP; Snape WJ; Lee L; Tonascia J; Hamilton F Clin Gastroenterol Hepatol; 2011 Jul; 9(7):567-76.e1-4. PubMed ID: 21397732 [TBL] [Abstract][Full Text] [Related]
50. A systematic review of surgical therapy for gastroparesis. Jones MP; Maganti K Am J Gastroenterol; 2003 Oct; 98(10):2122-9. PubMed ID: 14572555 [TBL] [Abstract][Full Text] [Related]
51. [Gastroparesis. Definition, diagnostics, and therapy]. von Arnim U Internist (Berl); 2015 Jun; 56(6):625-30. PubMed ID: 25940143 [TBL] [Abstract][Full Text] [Related]
52. Gastric Electrical Stimulation with the Enterra System: A Systematic Review. Lal N; Livemore S; Dunne D; Khan I Gastroenterol Res Pract; 2015; 2015():762972. PubMed ID: 26246804 [TBL] [Abstract][Full Text] [Related]
53. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction. Andersson S; Lönroth H; Simrén M; Ringström G; Elfvin A; Abrahamsson H Neurogastroenterol Motil; 2006 Sep; 18(9):823-30. PubMed ID: 16918761 [TBL] [Abstract][Full Text] [Related]
54. A slow caloric satiety drinking test in patients with temporary and permanent gastric electrical stimulation. Andersson S; Elfvin A; Ringström G; Lönroth H; Abrahamsson H; Simrén M Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):926-32. PubMed ID: 20087194 [TBL] [Abstract][Full Text] [Related]
55. Evaluation and treatment of gastric stimulator failure in patients with gastroparesis. Harrison NS; Williams PA; Walker MR; Nikitini Y; Helling TS; Abell TL; Lahr CJ Surg Innov; 2014 Jun; 21(3):244-9. PubMed ID: 24056201 [TBL] [Abstract][Full Text] [Related]
56. Investigational drug therapies for the treatment of gastroparesis. Sanger GJ; Pasricha PJ Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997 [TBL] [Abstract][Full Text] [Related]